Michael B. Harlin
Advertisement
Partner at Neal Gerber Eisenberg, specializing in life sciences intellectual property.
Articles by Michael B. Harlin
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
2
FDA Grants National Priority Voucher to Tecvayli Combination in Relapsed or Refractory Multiple Myeloma
3
FDA Approves Enhertu Plus Perjeta as First-Line Therapy for HER2-Positive Metastatic Breast Cancer
4
Brent Saunders: Eyeing New Horizons
5
